Stay updated on Nivolumab for Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab for Prostate Cancer Clinical Trial page.

Latest updates to the Nivolumab for Prostate Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.5.0 was added, replacing Revision: v3.4.3.SummaryDifference0.1%

- Check20 days agoChange DetectedRevision: v3.4.3 added; Prostate cancer, related topics, MedlinePlus Genetics, and Revision: v3.4.2 were removed from the page.SummaryDifference0.2%

- Check27 days agoChange DetectedAdded related topics 'Prostate cancer' and a link to 'MedlinePlus Genetics' to the page navigation.SummaryDifference0.2%

- Check49 days agoChange DetectedRevision: v3.4.2 was added, and the funding-lapse notice along with the prior Revision: v3.4.1 entry were removed.SummaryDifference0.4%

- Check56 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and updated the page revision from v3.4.0 to v3.4.1; there are no changes to the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check63 days agoChange DetectedThe changes are minor UI and metadata updates (Show glossary option; the label 'Last Update Submitted that Met QC Criteria'; capitalization adjustments; and a new revision version to v3.4.0) that do not alter core study content or data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Nivolumab for Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab for Prostate Cancer Clinical Trial page.